Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

4,045 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,045 results

Large-scale testing (Phase 3)Study completedNCT02939287
What this trial is testing

Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan

Who this might be right for
NauseaVomiting
Rush University Medical Center 52
Early research (Phase 1)Looking for participantsNCT05976555
What this trial is testing

Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma

Who this might be right for
Multiple Myeloma
Medical College of Wisconsin 30
Post-approval studies (Phase 4)Study completedNCT06425276
What this trial is testing

Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC Transplantation

Who this might be right for
Multiple Myeloma
CASI Pharmaceuticals (China) Co., Ltd. 67
Testing effectiveness (Phase 2)Study completedNCT05338047
What this trial is testing

Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery After Autotransplant

Who this might be right for
Myeloma MultipleLymphoma
Hospital Universitario Dr. Jose E. Gonzalez 30
Not applicableUnknownNCT05561049
What this trial is testing

Efficacy and Safety of Daratumumab in Combination With Bortezomib, Thalidomide, and Dexamethasone Regimens in Newly Diagnosed Multiple Myeloma

Who this might be right for
Newly Diagnosed Multiple Myeloma
The First Affiliated Hospital of Soochow University 120
Early research (Phase 1)Ended earlyNCT00311558
What this trial is testing

Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma

Who this might be right for
Cancer
The Cleveland Clinic 18
Not applicableStudy completedNCT07150468
What this trial is testing

Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells

Who this might be right for
Acute Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasms, Lymphoma, Multiple Myeloma
Asan Medical Center 146
Testing effectiveness (Phase 2)Active Not RecruitingNCT04656951
What this trial is testing

Daratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First Relapse

Who this might be right for
Multiple Myeloma
University of Cologne 67
Testing effectiveness (Phase 2)Looking for participantsNCT07605416
What this trial is testing

Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial

Who this might be right for
Plasma Cell Leukemia
National Cancer Institute (NCI) 74
Not applicableEnded earlyNCT02376933
What this trial is testing

Vertebral Augmentation and Radiotherapy of Collapse Spinal Metastatic Cancer

Who this might be right for
Metastatic CancersMultiple MyelomaVertebral Fracture
University of Arizona 11
Post-approval studies (Phase 4)Looking for participantsNCT07094048
What this trial is testing

Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager

Who this might be right for
Multiple Myeloma RefractoryRelapsed Multiple Myeloma
CHU de Quebec-Universite Laval 80
Early research (Phase 1)Study completedNCT02939183
What this trial is testing

Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Amgen 61
Not applicableUnknownNCT04727294
What this trial is testing

MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance+1 more
HealthTree Foundation 1,500
Post-approval studies (Phase 4)Looking for participantsNCT07101445
What this trial is testing

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Who this might be right for
Multiple Myeloma
Emory University 94
Not applicableWithdrawnNCT03660072
What this trial is testing

Postmarketing Study of Empliciti in Korean Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb
Large-scale testing (Phase 3)Not Yet RecruitingNCT07181239
What this trial is testing

Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma (MM)
Keymed Biosciences Co.Ltd 280
Testing effectiveness (Phase 2)Study completedNCT01919086
What this trial is testing

Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
Memorial Sloan Kettering Cancer Center 30
Early research (Phase 1)Looking for participantsNCT07660939
What this trial is testing

GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders

Who this might be right for
Plasma Cell DisordersMultiple Myeloma (MM)
Peking University First Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00083577
What this trial is testing

Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 250
Testing effectiveness (Phase 2)Study completedNCT01383928
What this trial is testing

Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 64
Next Page